PETER A PUZIO
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology FISHERSVILLE, VA NPI 1295795003
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology VA ABBVIE INC. All categories
General Payments — all program years on this page
$11,557.27
- Category: General Payments
- Program years: PY2018–2024
- Record count: 694
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,995.02 across 94 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,995.02 | 94 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $417.22 | 20 |
| UCB, Inc. | $217.10 | 10 |
| Lundbeck LLC | $130.80 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.70 | 4 |
| SK Life Science, Inc. | $87.93 | 3 |
| Alexion Pharmaceuticals, Inc. | $80.34 | 4 |
| ARGENX US, INC. | $80.06 | 3 |
| Amneal Pharmaceuticals LLC | $79.33 | 3 |
| Lilly USA, LLC | $73.06 | 4 |
| EMD Serono, Inc. | $72.70 | 3 |
| Mallinckrodt Hospital Products Inc. | $69.62 | 2 |
| MDD US Operations, LLC | $66.88 | 3 |
| Otsuka America Pharmaceutical, Inc. | $61.92 | 3 |
| Celgene Corporation | $56.25 | 3 |
| PFIZER INC. | $54.56 | 3 |
| Biogen, Inc. | $52.67 | 2 |
| Acerta Pharma LLC | $40.82 | 2 |
| Genentech USA, Inc. | $40.79 | 2 |
| Neurocrine BioSciences, Inc. | $40.00 | 2 |
| LivaNova USA, Inc. | $32.20 | 1 |
| EISAI INC. | $28.95 | 1 |
| E.R. Squibb & Sons, L.L.C. | $27.20 | 1 |
| Sumitomo Pharma America, Inc. | $25.73 | 1 |
| Merz Pharmaceuticals, LLC | $25.04 | 1 |
| TG THERAPEUTICS, INC. | $18.30 | 1 |
| Kyowa Kirin, Inc. | $15.85 | 1 |
By program year
Records — PY2024 (94)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.